Delavirdine is indicated in combination with protease inhibitors and nucleoside reverse transcriptase inhibitor for the treatment of HIV-infection.
英
美
- 抗HIV新药地拉韦定是一种非核苷类的逆转录酶抑制剂,是由法玛西亚普强公司研制开发的。